Abstract:Substance use disorders (SUDs) induce widespread molecular dysregulation in the nucleus accumbens (NAc), a brain region pivotal for coordinating motivation and reward. These molecular changes are thought to support lasting neural and behavioral disturbances that promote drug-seeking in addiction. However, different drug classes exert unique influences on neural circuits, cell types, physiology, and gene expression despite the overlapping symptomatology of SUDs. To better understand common and divergent molecular mechanisms governing SUD pathology, our goal was to survey cell-type-specific restructuring of the NAc transcriptional landscape in after psychostimulant or opioid exposure. We combined fluorescence-activated nuclei sorting and RNA sequencing to profile NAc D1 and D2 medium spiny neurons (MSNs) across cocaine and morphine exposure paradigms, including initial exposure, prolonged withdrawal after repeated exposure, and re-exposure post-withdrawal. Our analyses reveal that D1 MSNs display many convergent transcriptional responses across drug classes during exposure, whereas D2 MSNs manifest mostly divergent responses between cocaine and morphine, with morphine causing more adaptations in this cell type. Utilizing multiscale embedded gene co-expression network analysis (MEGENA), we discerned transcriptional regulatory networks subserving biological functions shared between cocaine and morphine. We observed largely integrative engagement of overlapping gene networks across drug classes in D1 MSNs, but opposite regulation of key D2 networks, highlighting potential therapeutic gene network targets within MSNs. These studies establish a landmark, cell-type-specific atlas of transcriptional regulation induced by cocaine and by morphine that can serve as a foundation for future studies towards mechanistic understanding of SUDs. Our findings, and future work leveraging this dataset, will pave the way for the development of targeted therapeutic interventions, addressing the urgent need for more effective treatments for cocaine use disorder and enhancing the existing strategies for opioid use disorder.

Smaller amygdala and medial prefrontal cortex predict escalating stimulant use.

N-Acetyl and Glutamatergic Neurometabolites in Perisylvian Brain Regions of Methamphetamine Users

Shared and Divergent Transcriptomic Regulation in Nucleus Accumbens D1 and D2 Medium Spiny Neurons by Cocaine and Morphine

Genome-wide transcriptional profiling of central amygdala and orbitofrontal cortex during incubation of methamphetamine craving

Compulsive Drug-Taking is Associated with Habenula–frontal Cortex Connectivity

A Prospective Longitudinal Study Shows Putamen Volume is Associated with Moderate Amphetamine Use and Resultant Cognitive Impairments

Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience.

Time-dependent changes in striatal monoamine levels and gene expression following single and repeated amphetamine administration in rats

Meta-analysis of Structural Brain Abnormalities Associated with Stimulant Drug Dependence and Neuroimaging of Addiction Vulnerability and Resilience

Effects of familial risk and stimulant drug use on the anticipation of monetary reward: an fMRI study

Amphetamine use disorder is associated with striatum hypoactivation during anticipation of loss and reward

Compulsive Drug Use is Associated with Imbalance of Orbitofrontal- and Prelimbic-Striatal Circuits in Punishment-Resistant Individuals

Abnormal striatal circuitry and intensified novelty seeking among adolescents who abuse methamphetamine and cannabis

Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users

Influence of Compulsivity of Drug Abuse on Dopaminergic Modulation of Attentional Bias in Stimulant Dependence.

Extra-striatal D2/3 receptor availability in youth at risk for addiction

Metabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A 1H MRS Study

Volumetric abnormalities of grey matter in methamphetamine dependent patients

Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence

Adolescent substance use initiation and long-term neurobiological outcomes: insights, challenges and opportunities

Risk Taking and the Adolescent Reward System: a Potential Common Link to Substance Abuse.